Kliničke studije za Rak jetre u državi Texas
24 studija za Rak jetre traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
Službeni tekst studije (engleski)
DESTINY-PANTUMOUR04
- Research Site, Dallas
U tijeku regrutacijaOpažajna studija
Od 18 do 130 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07124000National Liver Cancer Screening Trial
- UT Southwestern Medical Center and Parkland Hospital, Dallas
- Baylor College of Medicine, Houston
U tijeku regrutacijaFaza 4
Od 18 do 85 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06084234CREO - Microwave Ablation Feasibility Study
- Memorial Hermann-Texas Medical Center, Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07817147Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
- St. David's Medical Center, Austin
U tijeku regrutacijaOpažajna studija
Od 22 godina i više · Oba spola · Ažurirano 11. ruj 2026. · NCT06486454GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
- University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 10. ruj 2026. · NCT04864054A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- UT MD Anderson, Houston
- NEXT Oncology, San Antonio
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06440005Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
- Texas Children's Hospital, Houston
U tijeku regrutacijaFaza 1
Od 1 do 21 godina · Oba spola · Ažurirano 6. kol 2026. · NCT04715191Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT07010315Multi-analyte Blood Test Clinical Trial
- South Texas Research Institute, Edinburg
- Texas Gastro Research, El Paso
- Impact Research Institute, Waco
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT05199259A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
- NEXT Dallas, Dallas
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 7. srp 2026. · NCT07337525Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- JPS Health Network, Forth Worth
- Baylor Scott and White Biorepository, Temple
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 29. lip 2026. · NCT07327489A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
- Clinical Trial Site, San Antonio
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 17. lip 2026. · NCT06600321Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
U tijeku regrutacija
Od 18 do 75 godina · Oba spola · Ažurirano 17. lip 2026. · NCT05486572Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- START Dallas, Fort Worth
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 10. lip 2026. · NCT07517198Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 6. svi 2026. · NCT06239194A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 13. tra 2026. · NCT06362369The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Md Anderson Cancer Center, Houston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 5. ožu 2026. · NCT04075305Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
- Baylor College of Medicine, Houston
U tijeku regrutacijaFaza 2
Od 0 do 30 godina · Oba spola · Ažurirano 24. velj 2026. · NCT04134559A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
- NEXT Dallas, Dallas
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 21. sij 2026. · NCT07317505Sample Collection for Ongoing Research and Product Evaluation Study
- Natera, Inc., Austin
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 15. sij 2026. · NCT07318051SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Dallas
- Massive Bio SYNERGY-AI site, Houston
- Massive Bio SYNERGY-AI site, Temple
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774EGCG for Hepatocellular Carcinoma Chemoprevention
- UT Southwestern, Dallas
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 5. ruj 2025. · NCT06015022Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- Site 881, Dallas
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. tra 2025. · NCT05201404Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
- Houston Methodist Research Institute, Houston
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 1. velj 2023. · NCT05185505Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.